Academic Journal

MORF and MOZ acetyltransferases target unmethylated CpG islands through the winged helix domain

التفاصيل البيبلوغرافية
العنوان: MORF and MOZ acetyltransferases target unmethylated CpG islands through the winged helix domain
المؤلفون: Becht, Dustin C., Klein, Brianna J., Kanai, Akinori, Jang, Suk Min, Cox, Khan L., Zhou, Bing-Rui, Phanor, Sabrina K., Zhang, Yi, Chen, Ruo-Wen, Ebmeier, Christopher C., Lachance, Catherine, Galloy, Maxime, Fradet-Turcotte, Amelie, Bulyk, Martha L., Bai, Yawen, Poirier, Michael G., Côté, Jacques, Yokoyama, Akihiko, Kutateladze, Tatiana G.
المساهمون: U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences, U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute, U.S. Department of Health & Human Services | NIH | National Cancer Institute, U.S. Department of Health & Human Services | NIH | National Institute on Aging
المصدر: Nature Communications ; volume 14, issue 1 ; ISSN 2041-1723
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2023
الوصف: Human acetyltransferases MOZ and MORF are implicated in chromosomal translocations associated with aggressive leukemias. Oncogenic translocations involve the far amino terminus of MOZ/MORF, the function of which remains unclear. Here, we identified and characterized two structured winged helix (WH) domains, WH1 and WH2, in MORF and MOZ. WHs bind DNA in a cooperative manner, with WH1 specifically recognizing unmethylated CpG sequences. Structural and genomic analyses show that the DNA binding function of WHs targets MORF/MOZ to gene promoters, stimulating transcription and H3K23 acetylation, and WH1 recruits oncogenic fusions to HOXA genes that trigger leukemogenesis. Cryo-EM, NMR, mass spectrometry and mutagenesis studies provide mechanistic insight into the DNA-binding mechanism, which includes the association of WH1 with the CpG-containing linker DNA and binding of WH2 to the dyad of the nucleosome. The discovery of WHs in MORF and MOZ and their DNA binding functions could open an avenue in developing therapeutics to treat diseases associated with aberrant MOZ/MORF acetyltransferase activities.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1038/s41467-023-36368-5
الاتاحة: http://dx.doi.org/10.1038/s41467-023-36368-5
https://www.nature.com/articles/s41467-023-36368-5.pdf
https://www.nature.com/articles/s41467-023-36368-5
Rights: https://creativecommons.org/licenses/by/4.0 ; https://creativecommons.org/licenses/by/4.0
رقم الانضمام: edsbas.758F1B6A
قاعدة البيانات: BASE
الوصف
DOI:10.1038/s41467-023-36368-5